Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4

Cellular Signalling

Volumn 26, Issue 10, 2014, Pages 2249-2258

  Park, Soo Jin ^a,b   Lee, Kyoung Pil ^a,b   Kang, Saeromi ^a,b   Lee, Jaewon ^a,b   Sato, Koichi ^a,b   Chung, Hae Young ^a,b   Okajima, Fumikazu ^a,b   Im, Dong Soon ^a,b  

^a Pusan National University   (South Korea)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; HDL; M2 phenotype; Macrophage; S1P; Sphingosine 1 phosphate

Indexed keywords

ARGINASE 1; CELL PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN YM 1; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STAT6 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CELL SURFACE RECEPTOR; IL4RA PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SOCS1 PROTEIN, MOUSE; SOCS3 PROTEIN, MOUSE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; MOUSE MODEL; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DOWN-REGULATION; INTERLEUKIN-4; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; LYSOPHOSPHOLIPIDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; SPHINGOSINE; STAT6 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84904888917     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.07.009     Document Type: Article

References (40)

1. Libby P., Ridker P.M., Maseri A. Circulation 2002, 105(9):1135-1143.
2. Hansson G.K. N. Engl. J. Med. 2005, 352(16):1685-1695.
3. Vink A., de Kleijn D.P., Pasterkamp G. Curr. Opin. Lipidol. 2004, 15(5):515-521.
4. Curtiss L.K., Tobias P.S. J. Lipid Res. 2009, 50:S340-S345. (Suppl.).
5. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., Witztum J.L. Arterioscler. Thromb. Vasc. Biol. 2005, 25(6):1213-1219.
6. Cole J.E., Kassiteridi C., Monaco C. Trends Pharmacol. Sci. 2013, 34(11):629-636.
7. Bjorkbacka H., Kunjathoor V.V., Moore K.J., Koehn S., Ordija C.M., Lee M.A., Means T., Halmen K., Luster A.D., Golenbock D.T., Freeman M.W. Nat. Med. 2004, 10(4):416-421.
8. Rader D.J. J. Am. Cardiol. 2003, 92(4A):42J-49J.
9. Assmann G., Gotto A.M. Circulation 2004, 109(23 Suppl. 1):III8-III14.
10. Feig J.E., Rong J.X., Shamir R., Sanson M., Vengrenyuk Y., Liu J., Rayner K., Moore K., Garabedian M., Fisher E.A. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(17):7166-7171.
11. Sanson M., Distel E., Fisher E.A. PLoS One 2013, 8(8):e74676.
12. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. J. Immunol. 2005, 175(1):342-349.
13. Bouhlel M.A., Staels B., Chinetti-Gbaguidi G. J. Intern. Med. 2008, 263(1):28-42.
14. Moolenaar W.H., Hla T. Cell 2012, 148(1-2):378-378. (e372).
15. Okajima F. Biochim. Biophys. Acta 2002, 1582(1-3):132-137.
16. Murata N., Sato K., Kon J., Tomura H., Yanagita M., Kuwabara A., Ui M., Okajima F. Biochem. J. 2000, 352(Pt 3):809-815.
17. Christoffersen C., Obinata H., Kumaraswamy S.B., Galvani S., Ahnstrom J., Sevvana M., Egerer-Sieber C., Muller Y.A., Hla T., Nielsen L.B., Dahlback B. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(23):9613-9618.
18. Okajima F., Sato K., Kimura T. Endocr. J. 2009, 56(3):317-334.
19. Karuna R., Park R., Othman A., Holleboom A.G., Motazacker M.M., Sutter I., Kuivenhoven J.A., Rohrer L., Matile H., Hornemann T., Stoffel M., Rentsch K.M., von Eckardstein A. Atherosclerosis 2011, 219(2):855-863.
20. Sattler K.J., Elbasan S., Keul P., Elter-Schulz M., Bode C., Graler M.H., Brocker-Preuss M., Budde T., Erbel R., Heusch G., Levkau B. Basic Res. Cardiol. 2010, 105(6):821-832.
21. Argraves K.M., Sethi A.A., Gazzolo P.J., Wilkerson B.A., Remaley A.T., Tybjaerg-Hansen A., Nordestgaard B.G., Yeatts S.D., Nicholas K.S., Barth J.L., Argraves W.S. Lipids Health Dis. 2011, 10:70.
22. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Circ. Res. 2008, 102(8):950-958.
23. Kang S., Lee K.P., Park S.J., Noh D.Y., Kim J.M., Moon H.R., Lee Y.G., Choi Y.W., Im D.S. J. Ethnopharmacol. 2014, 153(1):242-249.
24. Youn C.K., Park S.J., Lee M.Y., Cha M.J., Kim O.H., You H.J., Chang I.Y., Yoon S.P., Jeon Y.J. Biomol. Ther. 2013, 21(4):258-263.
25. Kang J.I., Kim S.C., Han S.C., Hong H.J., Jeon Y.J., Kim B., Koh Y.S., Yoo E.S., Kang H.K. Biomol. Ther. 2013, 20(1):118-124.
26. Vo V.A., Lee J.W., Shin S.Y., Kwon J.H., Lee H.J., Kim S.S., Kwon Y.S., Chun W. Biomol. Ther. (Seoul) 2014, 22(1):10-16.
27. Whyte C.S., Bishop E.T., Ruckerl D., Gaspar-Pereira S., Barker R.N., Allen J.E., Rees A.J., Wilson H.M. J. Leukoc. Biol. 2011, 90(5):845-854.
28. Gordon S., Martinez F.O. Immunity 2010, 32(5):593-604.
29. Arthur J.S., Ley S.C. Nat. Rev. Immunol. 2013, 13(9):679-692.
30. Buono C., Come C.E., Stavrakis G., Maguire G.F., Connelly P.W., Lichtman A.H. Arterioscler. Thromb. Vasc. Biol. 2003, 23(3):454-460.
31. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. J. Clin. Invest. 1997, 99(11):2752-2761.
32. Feng J., Han J., Pearce S.F., Silverstein R.L., Gotto A.M., Hajjar D.P., Nicholson A.C. J. Lipid Res. 2000, 41(5):688-696.
33. Cornicelli J.A., Butteiger D., Rateri D.L., Welch K., Daugherty A. J. Lipid Res. 2000, 41(3):376-383.
34. King V.L., Szilvassy S.J., Daugherty A. Arterioscler. Thromb. Vasc. Biol. 2002, 22(3):456-461.
35. King V.L., Cassis L.A., Daugherty A. Am. J. Pathol. 2007, 171(6):2040-2047.
36. Chinetti-Gbaguidi G., Baron M., Bouhlel M.A., Vanhoutte J., Copin C., Sebti Y., Derudas B., Mayi T., Bories G., Tailleux A., Haulon S., Zawadzki C., Jude B., Staels B. Circ. Res. 2011, 108(8):985-995.
37. van Tits L.J., Stienstra R., van Lent P.L., Netea M.G., Joosten L.A., Stalenhoef A.F. Atherosclerosis 2011, 214(2):345-349.
38. Halvorsen B., Otterdal K., Dahl T.B., Skjelland M., Gullestad L., Oie E., Aukrust P. Prog. Cardiovasc. Dis. 2008, 51(3):183-194.
39. Weigert A., Johann A.M., von Knethen A., Schmidt H., Geisslinger G., Brune B. Blood 2006, 108(5):1635-1642.
40. Weigert A., Brune B. Nitric Oxide 2008, 19(2):95-102.